Titan (6)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE notifies trading members of suspension of trading in commercial papers of 15 companies with record dates for redemption falling on 13-15 … | |||||||||||||||
BSE notifies trading members of suspension of trading in commercial papers of 15 companies with record dates for redemption falling on 13-15 March 2026, effective from 13 March 2026.
| |||||||||||||||
BSE advises trading members not to deal in commercial papers of 19 companies that have fixed record dates for redemption between March 6-10, … | |||||||||||||||
BSE advises trading members not to deal in commercial papers of 19 companies that have fixed record dates for redemption between March 6-10, 2026.
| |||||||||||||||
BSE notifies trading members of suspension of dealings in commercial papers of 19 companies with record dates between March 6-10, 2026 for … | |||||||||||||||
BSE notifies trading members of suspension of dealings in commercial papers of 19 companies with record dates between March 6-10, 2026 for redemption purposes.
| |||||||||||||||
BSE notifies suspension of trading in commercial papers of 18 companies including Axis Finance, Kotak Mahindra Prime, ICICI Securities, Tata … | |||||||||||||||
BSE notifies suspension of trading in commercial papers of 18 companies including Axis Finance, Kotak Mahindra Prime, ICICI Securities, Tata Steel, and others, ahead of their redemption record dates on 05 and 06 March 2026.
| |||||||||||||||
BSE notifies trading members of suspension of dealings in commercial papers of 18 companies with record dates of 05 March 2026 and 06 March … | |||||||||||||||
BSE notifies trading members of suspension of dealings in commercial papers of 18 companies with record dates of 05 March 2026 and 06 March 2026 for redemption purposes.
| |||||||||||||||
Titan Biotech Ltd has announced a 1:5 stock split, subdividing each equity share of Rs.10/- face value into five equity shares of Rs.2/- … | |||||||||||||||
Titan Biotech Ltd has announced a 1:5 stock split, subdividing each equity share of Rs.10/- face value into five equity shares of Rs.2/- face value, effective February 20, 2026.
| |||||||||||||||